0001213900-22-057513.txt : 20220920
0001213900-22-057513.hdr.sgml : 20220920
20220920191107
ACCESSION NUMBER: 0001213900-22-057513
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220919
FILED AS OF DATE: 20220920
DATE AS OF CHANGE: 20220920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Claiborne Cary J
CENTRAL INDEX KEY: 0001370930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38323
FILM NUMBER: 221254776
MAIL ADDRESS:
STREET 1: 3056 SENECA CHIEF TRAIL
CITY: ELLICOTT CITY
STATE: MD
ZIP: 21042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001513525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 800667150
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 SEMINOLE TRAIL
STREET 2: SUITE 495
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22901
BUSINESS PHONE: 434-422-9800
MAIL ADDRESS:
STREET 1: 1180 SEMINOLE TRAIL
STREET 2: SUITE 495
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22901
FORMER COMPANY:
FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C.
DATE OF NAME CHANGE: 20170515
FORMER COMPANY:
FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C.
DATE OF NAME CHANGE: 20110218
4
1
ownership.xml
X0306
4
2022-09-19
0
0001513525
ADIAL PHARMACEUTICALS, INC.
ADIL
0001370930
Claiborne Cary J
1180 SEMINOLE TRAIL, SUITE 495
CHARLOTTESVILLE,
VA
22901
1
1
0
0
Chief Executive Officer
Common Stock
2022-09-19
4
A
0
25000
0.4294
A
1025000
D
Common Stock
2022-09-20
4
A
0
75000
0.4202
A
1100000
D
The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4196 through $0.4573, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4079 through $0.4230, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Cary J. Claiborne
2022-09-20